Abstract. The ability of SV40 T antigen to cause abnormalities in cartilage development in transgenic mice and chimeras has been tested. The cis-regulatory elements of the COL2A1 gene were used to target expression of SV40 T antigen to differentiating chondrocytes in transgenic mice and chimeras derived from embryonal stem (ES) cells bearing the same transgene. The major phenotypic consequences of transgenic (pAL21) expression are malformed skeleton, disproportionate dwarfism, and perinatal/neonatal death. Expression of T antigen was tissue specific and in the main characteristic of the mouse od(ID collagen gene. Chondrocyte densities and levels of ot I(ID collagen mRNAs were reduced in the transgenic mice. Islands of cells which express cartilage characteristic genes such as type fib procollagen, long form or(IX) collagen, o~2(XI) collagen, and aggrecan were found in the articular and growth cartilages of pAL21 chimeric fetuses and neonates. But these cells, which were expressing T antigen, were not properly organized into columns of proliferating chondrocytes. Levels of od0l) collagen mRNA were reduced in these chondroeytes. In addition, these cells did not express type X collagen, a marker for hypertrophic chondroeytes. The skeletal abnormality in pAL21 mice may therefore be due to a retardation of chondrocyte maturation or an impaired ability of chondroeytes to complete terminal differentiation and an associated paucity of some cartilage matrix components.
elements of the COL2A1 gene were used to target expression of SV40 T antigen to differentiating chondrocytes in transgenic mice and chimeras derived from embryonal stem (ES) cells bearing the same transgene. The major phenotypic consequences of transgenic (pAL21) expression are malformed skeleton, disproportionate dwarfism, and perinatal/neonatal death. Expression of T antigen was tissue specific and in the main characteristic of the mouse od(ID collagen gene. Chondrocyte densities and levels of ot I(ID collagen mRNAs were reduced in the transgenic mice. Islands of cells which express cartilage characteristic genes such as type fib procollagen, long form or(IX) collagen, o~2(XI) collagen, and aggrecan were found in the articular and growth cartilages of pAL21 chimeric fetuses and neonates. But these cells, which were expressing T antigen, were not properly organized into columns of proliferating chondrocytes. Levels of od0l) collagen mRNA were reduced in these chondroeytes. In addition, these cells did not express type X collagen, a marker for hypertrophic chondroeytes. The skeletal abnormality in pAL21 mice may therefore be due to a retardation of chondrocyte maturation or an impaired ability of chondroeytes to complete terminal differentiation and an associated paucity of some cartilage matrix components.
URING vertebrate development, the establishment of a cartilage template involves the orderly differentiation of chondrocytes. This is important as the template forms a temporary framework for the formation of endochondral bone (Horton, 1993) . Cartilage also is important because it has to withstand high cyclical loads and absorb shocks. This is achieved by the synthesis of a complex extracellular matrix, consisting of hyaluronate-proteoglycan complexes (Rosenberg and Buckwalter, 1986) and at least five different collagens, type II, VI, IX, X, and XI (Mayne and Irwin, 1986 ), one of the major components of which is type II collagen. There is growing evidence that mutations in the human oil(l/) collagen gene (COL2A1) ~ can cause some inherited chondrodysplasias, disorders which result in skeletal abnormalities characterized by disproportionate dwarfism (Spranger and Maroteaux, 1990; Horton and Hecht, 1993) . Mutations in COL2A1 have been implicated in Stickler syndrome (Francomano et al, 1987; Ahmad et al., 1991 Ahmad et al., , 1993 Brown et al., 1992; ; W'mterpacht et al., 1993) , Kniest dysplasia (Winterpacht et al., 1993; Poole et al., 1988) , lethal (Langer-Saldino) aehondrogenesis , spondyloepiphyseal dysplasia Tiller et al., 1990; Cole et al., 1993; Vikkttla et al., 1993a) , Goldblatt syndrome (Bonaventure et al., 1992) , hypochondrogenesis (Horton et al., 1992) , and also in primary generalized osteoarthfitis (Palotie et al., 1989; Vikkula et al., 1993b; Knowlton et al., 1990; Ala-Kokko et al., 1990) . Dominant negative mutations in the ~ 1(I1) collagen gene expressed in transgenic mice result in severe chondrodysplasia (Mets~ranta et al., 1992; Garofalo et al., 1991; Vandenberg et al., 1991) . These studies confirm the association of mutations in COL2A1 with some forms of human ehondrodysplasia. However, over 150 different ehondrodysplastic conditions have been described in humans varying from being perinatal lethal, to deforming during life, to being so mild that they are difficult to detect (Spranger and Maroteaux, 1990; Horton and Hecht, 1993) . The molecular bases underlying these disorders are largely unknown. SV40 T antigen (Tag) is the major multifuncfional regula-tory protein of simian virus 40 and has multiple regulatory effects on eukaryotic cells (Stahl and Knippers, 1987; Butel and Jarvis, 1986; Fanning and Knippers, 1992 DNA sequences sufficient to direct tissue specific expression of the human COI.2A1 gene in mice have been previously identified (Lovell-Badge et al., 1987b) and cell transfection studies have shown that the first intron of the rat al(II) collagen gene contains a chondrocyte specific enhancer element (Horton et al., 1987) . Since the first introns of the rat and human od(I~ collagen genes show high degree of conservation , it was likely that the human intron sequences also contain a similar cartilage specific enhancer element. We therefore constructed a chimeric plasmid containing 4.5 kb of 5' flanking DNA and 1.8 kb from the first intron of the human COL2A1 gene linked to the Tag gene and introduced this construct (pAL21, see Fig. 1 ) into the mouse germline by transgenesis. This paper reports that the phenotypic consequence of carrying this COL2A1-Tag transgene is major skeletal malformation, disproportionate dwarfism, and perinatal death in the transgenic mice. Expression of Tag was tissue specific and we also show that the likely cause of the skeletal abnormality may be an impaired ability of chondrocytes to differentiate properly.
Materials and Methods

Generation and Identification of Tmnsgenic and Chimeric Mice
Two plasmids were used to generate lransgenic mice (see Fig. 1 [Cheah et al., 1985] ). DNA inserts of plasmids pAL21 and pAA2 were released using KpnI and NotI and NotI alone, respectively (Fig. 1) , and microinjected into the pronuclei of one cell embryos from F1 hybrid mice (C57BL/6 × CBA/N). Transgenic mice were identified by PCR, Southern blot or dot blot analyses of genomic DNA prepared from the tails of embryos or recently weaned mice. Identification of pAL21 transgenic mice by PCR was performed using nested ollgenucleotide primers to the early region of the Tag gene (GenBank accession No. J02400) as follows: primer 1, 5'-TCAGC~-GGAGGTGTGGGAGG-3' (nt 2704-2723); primer 2, 5'-~.C~,3G-A~GTCCA-3' (complementary to nt 3371-3390); primer 3, 5'-GAG-CC~TGTGAATC-3' (nt 2808-2828) and primer 4, 5'-CCTAAA-ACACTGCAGGCCAG-3' (complementary to nt 3198-3217). PCR amplifications were for a first round of 20 cycles of denaturation at 94°C 0.1 min, annealing 65°C, 0.5 min and synthesis (2.5 U Taq polymerase, Ceres Corp.), 72°C 0.5 win usin 8 primers 1 and 2, followed by a second round of 20 cycles using 1 ~tl from the first reaction and primers 3 and 4. The transgenic identities of pAL21 mice were confirmed by Southern hybridizations of BamHI digested genomic DNAs using a 2.7-kb BamHI fragment from pAL21 as a probe, pAA2 mice were identified by the PCR using the following oligonucleotide primers for the E. coli lacZ gene:5'-CGTAATAGC-GAAGAGC~CCG-3'; 5'-TCCAAC~CCATCACC-3' (nt 112-130, and complementary to nt 558-577, respectively; translation start ffi 1).
DNA insert from pAL21 (25 ~tg) and 250 ng of BamHI linearised plasmid carrying the neomycin resistance geue, (pGKneo, gift of R, Krumlauf, National Institute for Medical Research, London, UK) was incorporated into the genome of CCE embryonal stem (ES) cells (gift of E. Robertson, Harvard University) by electroporation at 160 V, 960/tF using a Gene Pulser apparatus (BinRad Labs., Hercules, CA). After growth in medium (l~bertson, 1987) containing 0.4 mg/ml C,418, resistant ES colonies were selected, and the presence of Tag transgene was confirmed by Southern blot analysis. Mouse chimeras were generated by injecting cells from a CCE line carrying four copies of pAL21 into C57BI/6J blastocysts (Bradley, 1987) . Chimerism was determined on the basis of agonti pigmentation in the coat and by determination of copy number of pAL21 in somatic tissues.
RNA Probes, RNA Analyses, and In Situ Hybridization
Riboprobe for the detection of mouse ~10I) collagen mRNAs in RNase protection assays were transcribed in vitro using plasmid pELlll which contains exon 1 as described previously (Cheah et al., 1991) . Probes for Col2a-1 mRNAs used for in situ hybridization were pSOK10, contalnin~ the alternatively spliced exon 2 characteristic of type ILA procollagen mRNA and pELIll (Cheah et al., 1991; Ng et al., 1993) . "Ihg mRNAs were detectnd by RNase protection assays using a riboprobe transcribed from pKC32 ( Fig. 1 [Haushan, 1985] ).
od(IX) short form and long form collagen (Mura~i et al., 1990) probes, pNJ59 and pNJ60 respectively, were made by RNA-PCR. Single-stranded eDNA was transcribed from 40 ~g of 17.5-d fetal total RNA by AMV reverse transcriptase (35 U, Seikagaku America Inc., Rockville, MD) using a primer complementary to exon 8 of the mouse al(IX) collagen gene (5'-CC~_CTC~-3') in 0.05 M Tris-HCl, pH &3, 75 mM KC1, 3 mM MgCI2, 125/~M each of dATP, dCTP, dGTP, and dTTP at 42°C for 30 min. This eDNA was used as template for generating pNJ59 and pNJ60 by the PCR. pNJ59 was made using oligonucleofide primers complementary to exon 1" of mouse od(IX) collagen gene (5'-ATGGCC-~CTGGC~-3', as 5' primer and 5'-TTGAFJC~GCACACAA-GCGGA-3', as 3' primer), pNJ60 was made using an oligenucleotide primer corresponding to exon 4 ([5'-GTAGACTICAGGATTCCA-3'] as 5' primer) and exon 6 (5'-AGCATCCACTGGAGTTCAAA-3') as 3' primer. The PCR was carried out in buffer containin~ 10 mM Tris-HCl, pH 8.3, 50 mM KCI, 1.5 mM MgCI2, 375/tM each of dATP, dCTP, dGTP, dTTP, 50-ng primers, and 5 U Taq polymerase (Perkin-Elmer Cetus Corp., Norwalk, CT) as follows: 1 min denaturation of DNA, 94eC; 1 min anlg~lin~ reaction, 65°C; 2 rain extension reaction, 72°C for 30 cycles. Both the RNA-PCR products were cloned in pGEM7-Zf(+) (Promege Corp., Madison, WI).
The ot2(XI) collagen probe was pVLm3B1 which contained a 900-bp BamHI fragment encoding part of the C-propeptide of the mouse ¢2(X1) collagen gene (Lui, C.-Y., L. J. Ng, and K. S. E. Cheah, manuscript in preparation) subcloned in pUBS (gift from G. Murphy, John Innes Institute, Norwich, UK). pNJ62 contained a 800-bp Kpnl-BamHI frasment of mouse aggrecan eDNA (generous ~ from Y. Yamnda, National Institute of Dental ~h, Bethesda, MD) subcloned in pGEM7-Zf(+). Mouse type X collagen probe was pRK26, encoding part of the COOH-terminal noncollagenous domain and 3' untranslated region (Kong et al., 1993) . Mouse od(I) collagen probe contained exon 2 of the gene (Cheah et al., 1991) .
Total RNA was prepased from heads, limbs, or ribs of embryos by the lithium chloride-urea method (Lovell-Badge, 1987) . RNase protection assays and in situ hybridization were carried out as described (Cheah et al., 1991) .
Immunohistochemistry and Western Blot Analyses
Ctyostat sections (7/an) fixed in acetone were immunostained using a mouse monoclonal antibody (ID9) specific for SV40 large T antigen (gift of David Lane, University of Dundee, Scotland) as described (Clw~ et al., 1991) . Protein was extracted from mouse fetal limbs or neonate tissues (Fig. 6, see legend) and from a Tag expressing monkey epithelial cell line, 483/SV40 (gift of Beverley Griffin, Royal Postgraduate Medical School, London, UK). Cells/tissues were resuspended in 4% SDS, 20% glycerol, 125 mM Tris-HCl, pH 6.8, 1% 2-mercaptoethanol and disrupted by sonication on ice. Samples were boiled for 5 rain, cell debris removed by centrifugation for 10 rain at 10,000 g. Proteins were separated by SDS-PAGE and transferred to Hybond C Super membrane (Amersham Corp., Arlington Heights, IL). Membranes were prehybridized for 2 h at 20°C in 5 % nonfat dry milk, PBS, 0.3% Tween 20 (PBST), and hybridized with ID9 antibody overnight at 4°C in PBST. After washing in PBST, membranes were incubated for I h with peroxidase-conjngated second antibody and the hybridization signal detected using Amersham's ECL system and Fuji RX film.
Results
COL2AI Regulatory Elements in pAL21 Confer 7Issue Specificity of Transgene Expression
The potential of the COL2A1 regulatory elements to direct Tag expression with proper tissue specificity was assessed by injecting a control construct similar to pAL21 except that Tag was replaced by the/acZ gene (pAA2, Fig. 1 ). The pattern of expression of/acZ in pAA2 transgenic fetuses obtained from different injection experiments was monitored at 9.5, 12.5, and 13.5 d. Fig. 2 shows that in a 12.5-d pAA2 transgenlc embryo, lacZ staining was detected in sites expected for chondrogenic expression of od(ll) collagen mRNA. Low level expression was also seen in brain neuroepithelium. Similar results were obtained for 13.5-d fetuses (not shown). Histological sections of 9.5-d embryos show staining in the paraxial mesenchyme which gives rise to the chondrocranlum (data not shown). Strong and specific expression in precursors of the cartilaginous primordia of the skeleton such as in vertebrae, limbs, and chondrocranium was also found between 12.5-18.5 d in fetuses from a pAA2 transgenic line of mice (data not shown). Expression of pAA2 in different transgenic fetuses (not shown, Leung, K. K. H., and K. S. E. Cheah, unpublished results) generally correlates with the pattern of expression of the mouse Col2a-1 gene in chondrogenic and nervous tissues (Wood et al., 1991; Cheah et al., 1991) , confirming that Tag expression could be targeted with proper tissue specificity by the COL2A1 regulatory elements in pAL21 mice.
pAL21 Transgenesis Is Associated with Perinatal Lethality and Abnormality, Not Tumorigenesis
Only 15 pAL21 transgenlc mice were found among 184 adults, a low rate of 8 % compared to a 32 % transgenesis rate for adults obtained from injections using pAA2 (Table I) . These pAL21 transgenic founders were morphologically normal and none developed tumors (at 2-3 years of age) before death of natural causes. Five founders were sterile and two others failed to transmit the transgene. Of the remaining 8 fertile founders, none of the transgenic offspring developed tumors. Female founder 123 produced a litter of 9 with only one transgenic pup which died at 11 d after birth of unknown cause and necropsy revealed no obvious anatomical abnormality. Founder 123 failed to breed thereafter and died naturally at 2.3 yr. Male founder 124 transmitted the transgene to only one out of 22 offspring. Back-crossing the transgenic offspring to founder 124 gave one normal heterozygous male and 2 abnormally small mice which were homozygous. The abnormal pups were cannibalized shortly afterward, leaving no tissues for biochemical or histological analyses. Two ab- (Cheah et ai., 1985) normally small mice were produced from the heterozygous offspring of mouse 124 and both died of unknown cause near to weaning age. Cannibalization of these mice precluded autopsy. To determine if the low incidence of pAL21 transgenic mice at weaning age reflected cannibalization at birth and/or lethality in utero, the transgenesis rate and litter sizes were determined at different stages of gestation between 10.5 to 18.5 days post coitum (d.p.c.). The pAL21 transgenesis rate Fetuses were harvested at various time points. To take into account the variations in embryo transfer between experiments and to allow inter-litter comparison, liner sizes wre normalized on a per 30 embryo-transferred basis. * Overall incidence of mmsgenesis for fetal stages: pAL21 = 38.2%; pAA2 = 41.4%.
was higher for fetuses (overall 38%) than for newborns (17%), but the litter size remained relatively constant up to 18.5 d.p.c. (Table I ). There was a high incidence of abnormality and/or stillbirth (37%) in newborn litters obtained from pAL21 injections and the majority (75 %) of the abnormal newborns were transgenic. The results suggested that pAL21 transgenic mice were probably being lost during the perinatal period. There was a further loss of pAL21 pups during suckling, resulting in a significant drop in transgenic frequency at weaning age. Overall 78 (36%) pAL21 transgenic fetuses between 10.5 and 18.5 d were found to display morphological defects compared to a 9 % incidence of abnormality among their nontransgenic littermates. Abnormalities associated with pAL21 transgenesis were first identified in 20% of the 11.5-d fetuses and the frequency of recognizable defects increased steadily to 44.3% at 18.5 d.
To test if the neonatal lethality and abnormality was associated with the Tag transgene or was caused by competition between the COL2A1 sequences and the endogenous Col2a-1 promoter for transcription factors, a comparison of transgenesis rates was made for injections using pAA2. The transgenesis frequencies and litter size at birth for pAA2 fetuses were similar to that of pAL21 up to 19.5 d.p.c. (Table  I) . A significantly higher transgenic frequency was found for pAA2 at birth and at weaning, and few pups died at birth or showed developmental retardation. Only 1 out of 51 pAA2 embryos and 2 out of 113 nontransgenic littermates at fetal stages displayed developmental retardation (small size) and the frequency of abnormality and lethality for transgenic pAA2 animals at birth was also low (11%). Overall, for experiments using pAA2, 9 % of transgenic animals and 6 % of nontransgenic littermates were abnormal.
The Major Abnormality in pAL21 Transgenic Mice Is Skeletal Malformation
Characteristic abnormalities in transgenlc pAL21 newborn mice were foreshortened limbs with stumpy digits, flattened faces, abnormal neck and shoulder posture, short trunk, subcutaneous edema, and lethargic movement (Fig. 3) . Alizarin red-alcian blue staining of skeletons (Fig. 4 A-C [Kessel and Gruss, 1991] ) showed (a) retarded ossification of the craniofacial skeleton, (b) inappropriate sizes of skeletal components, (c) poorly developed cervical vertebrae resulting in hyperextension and shortening of the neck, and (d) the lack of chondrification, exemplified by the reduced alcian blue-stained matrix in otic capsules and laryngeal skeleton, and in an extreme case, the absence of frontonasal cartilage.
The types of abnormality associated with pAL21 and pAA2 fetuses are shown in Table I1 . Among the various types of defects present in the pAL21 fetuses, smaller body size and foreshortened limbs were the most frequently encountered. There was also a specific predominance of defects of the craniofacial, axial, and appendicular skeleton, and the brain in pAL21 fetuses. Skeletal abnormalities included shortening and/or hyperextension of the neck (11% of the transgenic pAL21 fetuses), reduction of limb (22%) and digit lengths (7%), and reduced head size and snout length (10%). Approximately 35% (24/69) of abnormal pAL21 transgenic fetuses displayed multiple skeletal defects. The frequency of multiple skeletal defects in abnormal nontrans- genic animals from pAL21 injections was 7.4% (2/27) and none were observed for pAA2. Morphometric analyses of pAL21 transgenic fetuses at 15.5 and 18.5 d revealed a progressive reduction of head size and limb length and also a preferential reduction in the length of distal limb segments (Table HI) . Histological examination of the craniofacial structures revealed the poor differentiation of nasal septum, deformed and foreshortened cartilage of the base of the neurocranium. This deficiency in the midline chondrogenic tissues resulted in the medial and ventral displacement of craniofacial structures such as the inner ear, jaws, and nasal cavities (Fig. 5 ). However cleft palate was not observed.
Retarded brain development was observed in some transgenic fetuses (18 %). There was poor differentiation of neuronal layers of the brain, disproportionate growth of the midbrain and forebrain, retarded development and inadequate foliation of the cerebellum, and a general reduction of brain size, which may be secondary to poor skull development (Fig. 5) .
Tissue Pattern of Expression of Tag in pALM Mice Is Characteristic of ~ II Collagen
The tissue pattern of expression of the COL2A1-Tag transgene was assessed in fetuses between 12.5 d and 18.5 d and in newborns using RNase protection assays, Western analyses and immunohistochemistry. RNase protection assays yielded protected fragments of expected size, suggesting cor- Figure 4 . Alizarin-alcian blue skeletal preparations of (.4) normal and (B and C) abnormal transgenic pAL21 newborn. Newborn mice were eviscerated and the skeletons were stained with alizarin red S and alcian blue (Kessel and Gruss, 1991) . The transganic pups display hyperextended neck due to the thinner posterior arches (pa) of cervical vertebrae and the congested intervertebral space. Chondrification is diminished in the sutural bone such as the temporal and supra-occipital components of the skull (sk), and in the larynx and trachea (arrow). The orbital cavity is oversized, but mandible and maxilla (jw) are underdeveloped. Pup (C) in addition shows a severely deficient frontonasal cartilage (fn). Bar, 5 nun.
rect initiation of transcription. Tag-specific antibody detected a 97-kD polypeptide expected for Tag in Western analyses, indicating that the transgene m R N A was properly translated (Fig. 6) . Not all transgenic animals expressed Tag but a significant proportion did. Including fetuses and newborns, the total number where Tag m R N A could be detected was 22 animals out of 59 tested. Of 26 pAL21 transgenic Fetuses from pAL21 and pAA2 experiments collected at various times of gestation (Table I) were first examined macroscopically for morphological assessment and processed histologically for determination of tissue abnormalities. * Overall incidence of abnormal transgenic fetuses: pAL21 = 36.4% (78/214); pAA2 = 6.3% (8/126). * Incidence of defect type in pAL21 transganic fetuses. ArT, non-transgenic. T, transgenic.
ND, not determined.
newborns tested, Tag expression was detected by both Western analysis and RNase protection assays in 10, of which 8 displayed abnormalities such as reduction in limb length and short snouts. A representative selection of analyses is shown in Fig. 6 . Immunohistology performed on 44 pAL21 transge~ic fetuses revealed specific localization of Tag in chondrocytes in 48 % of abnormal animals (Fig. 7 A) , and, in some of these, a low level expression in neural tissues (data not shown). Tag expression was also detected by RNase protection in 12.5 d whole embryos and by immunostaining in the cartilage of fetuses at 14.5 d (data not shown). Nine of 14 abnormal new- (Fig. 1) horns were positive for Tag immunostaining of chondrocytes. Bone, mesenchyme, muscle, and skin were not stained which is consistent with the absence of type O collagen in these tissues (Fig. 7 A/and data not shown). Consistent with the known nuclear localization of Tag in SV40-infected cells, expression was detected in the nucleus (Fig. 7 A2) . Levels of Tag expression as assessed by the intensity of immunostaining varied between transgenic mice, and there was no direct correlation with degree of abnormality. In 3 out of 10 pAL21 newborns of normal morphology, Tag staining in cartilage was patchy and at very low levels indicating these animals were probably mosaic for the transgene. In two of those animals (such as No. 174, Fig. 6 ), Tag expression could not be confirmed by RNase protection assays or Western blotting. Tag expression was found in offspring from only two of the pAL21 transgenic founders which survived to adulthood: 123 and 124, both of which produced abnormal offspring. The single transgenic offspring of 123 was expressing Tag in rib, limb, and calvaria at the time of death. Expression of Tag in line 124 was found at 14.5 d.p.c, but not in newborns. No expression of Tag was found at fetal or adult stages for the other 6 fertile transgenic lines which probably accounts for their normal phenotype and postnatal survival.
Chondrocyte Densities Are Reduced in pAL21 Transgenic Mice
A significant reduction (20--30%) of the cell population was found for the proliferative and prehypertrophic chondrocytes in different cartilaginous organs, including otic capsule, nasal septum, base of skull, vertebrae, occipital bone, digit, and humerus of the transgenic pAL21 fetuses, particularly at late gestation (Table IV) . The decreased number of chondrocytes cannot be attributed to an increase in matrix because to the contrary, amounts were reduced. In situ hybridization of tissue sections of pAL21 fetuses at 15.5, 17.5, 18.5 d and in newborns using a Col2a-1 gene probe showed reduced levels of hybridization (Fig. 7, B-G) . The density of silver grains over the five cartilaginous tissues from a range of pAL21 transgenic and nontransgenic fetuses was examined and compared in experiments using the same riboprobe and identical exposure times. Levels of hybridization in chondrogenic tissues were very high for nontransgenic fetuses. Low levels of hybridization were found in '~20% of the pAL21 fetuses and were associated with severe abnormalities in cartilaginous structures (Fig. 7, D and E) . The remaining pAL21 fetuses displayed moderate to strong levels of hybridization (Fig. 7 C) . Transgenic fetuses showing strong levels of hybridization were morphologically normal. In the growth plate shown in Fig. 7 G, fewer cells were positive for od(X) collagen, a marker for hypertrophic chondrocytes (data not shown).
It was not possible in every case to determine if the lower levels of hybridization seen reflected a decrease in chondrocyte numbers alone or included reduced levels of Col2a-1 mRNAs on a per cell basis. However, the lower level or absence of hybridization in hypertrophic chondrocytes seen in several pAL21 animals compared to wild-type (Fig. 7, F and G) indicates that cellular levels of Col2a-1 mRNAs were reduced. In two fetuses hybridization was high in the morphologically normal vertebrae but was low in the under developed nasal septum. In two neonates with craniofacial abnormalities, reduced hybridization signal was found in the otic capsule and growth plate of the humerus (Fig. 7, D and G) but not in proliferating chondrocytes of vertebrae. Lowered hybridization levels found only in abnormal cartilage but not in morphologically normal cartilaginous structures in a single animal suggests a direct association between cartilage abnormality and a reduction in cell density and/or type II collagen gene expression.
pAL21 Chimeras Show Skeletal Malformation and Abnormal Chondrocyte Differentiation
Due to the dominant perinatal lethal effect of the Tag transgene in pAL21 mice, and because each individual transgenic newborn or embryo is the product of unique integrations Chondrocyte density was estimated on stained sections of pAI.,21 transgenic and wild-type 15.5-, 17.5-, and 18.5-d fetuses. The total number of chondrocytes (proliferating and prehypertrophic) was scored in a defined area of the cartilage. Scoring was done at 20 magnification and three separate counts were obtained from each section. *p < 0.05. t p < 0.01. § p < 0.001. II p < 0.0556. I p < 0.0079: significant difference in chondrocyte density between pAL21 fetuses and nontransgenic littermates. ND, not determined. d.p.c., days post coitum.
leading to variable severity of phenotype, a developmental analysis of the effect of COL2A1 targeted Tag expression on chondrocyte differentiation and on postnatal skeletal development was not possible. To overcome this difficulty, embryonic stem (ES) cells which carry integrated copies of pAL21 were used to produce mouse chimeras. Four of these chimeras have survived to neonatal stages but were typically smaller than normal non-chimeric mice and displayed severe kyphosis (Fig. 8 A) and retarded ossification of the skeleton. Severity of phenotype correlated well with the degree of chimerism (data not shown). Analyses of two such chimeric neonates, revealed the presence of islands of cells within articular cartilage with densely packed cells (Fig. 8) and reduced intercellular toluidine blue staining indicating reduced amounts of matrix (not shown). Similar islands of cells were found in the epiphyseal growth plate of lone bones but they were not organized into columns of proliferating chondrocytes. These islands of cells could also be found in a chimeric fetus at 15.5 d (Fig. 8 K) , which also showed disorganization of other cartilages such as otic capsule and carpals of the foot plate (data not shown). Tissue specific expression of Tag in the chimeric neonates could be demonstrated by RNA and protein analyses. In situ hybridization showed that the cells within these islands expressed Tag mRNAs, which were absent in normally organized chondrocytes, perichondrium, skin, and muscle (Fig. 8 B) . Expression of Tag in cartilaginous tissues was also confirmed by Western analyses of protein extracted from chimeric tissues (data not shown).
Chondrogenesis is a multistep process whereby mesenchymal cells differentiate into chondrocytes which mature, proliferate, and finally become hypertrophic. These stages of differentiation are marked by the expression of characteristic mRNAs. Type II procollagen mRNAs are alternatively spliced to give a type IIA form which contains an extra exon encoding a cysteine-rich domain or type lib form without this exon . The HA form is preferentially expressed by prechondrocytes and proliferating chondrocytes but not by mature or hypertrophic chondrocytes (Sandell et al., 1991; Ng et al., 1993) . Differentiated chondrocytes (mature, proliferating, and hypertrophic) express the type fib form. There are two alternative transcripts for the od(IX) collagen gene, one encoding a long form tx chain with a 266-amino acid globular domain, and the other, a short form tx chain without. In chick and mouse, maturing and proliferating chondrocytes express long form txl(IX) collagen mRNA whereas the short form is restricted to prechondrocytes and non-chondrogenic tissues (Swiderski and Solursh, 1992a,b; Liu et al., 1993 ; Ng, L. J., P. P. L. Tam, and K. S. E. Cheah manuscript in preparation). Type X collagen is only expressed by hypertrophic chondrocytes (Schmid and Linsenmayer, 1987) . Chondrocytes do not express type I collagen (Cheah et al., 1991) and its synthesis is a sign of dedifferentiation (Benya and Brown, 1986) .
The identity of the cells within the islands and their state of differentiation was assessed by the expression of genes which are characteristic markers for chondrocytes. These cells hybridized with the exon 1 probe of Col2a-1 gene albeit at a lower level compared to their surrounding normal counterparts (Fig. 8 C) . The absence of hybridization to the type llA-specific probe shows the islands of cells were expressing type liB procollagen (Fig. 8, C1 and G). These cells also expressed mRNAs for o~2(XI) collagen, the long form of od(IX) collagen, and aggrecan (Fig. 8, D-F) . Levels of expression of other cartilage characteristic mRNAs, such as aggrecan and o~2(XI) collagen mRNAs were not affected in the disorganized chondrocytes (Fig. 8, D-F) . There was no expression of mRNAs for od(I) collagen, the short form of od(IX) collagen, and type X collagen (Fig. 8, H-J) .
Discussion
The skeletal abnormalities displayed by pAL21 mice resemble the disproportionate dwarfism seen in human chondrodysplasia and in those transgenic mice carrying mutant Col2a-1 alleles (Metsiranta et al., 1992; Garofalo et al., Figure 8 . Expression of Tag and gene markers on chondrocyte differentiation in articular cartilage and growth plate of pAL21 chimeric mice. In situ hybridization study of genes expressed in the epiphyses of pAL21 chimeric mice. Sections (B-J) were counterstained with Harris haematoxylin-eosin after in situ hybridization. B, C2, G, I, and J are pictures taken under dark-field ilJumination. D-F and H are double exposures as described for Fig. 7 . C1 is a bright-field picture of C2. Sections K1 and K2 were counterstained 1% toluidine blue. The greenish color seen in the durk-field pictures G and I is due to histological staining of the emulsion. (A) An 8-d-old chimeric pup (C21.6) produced using ES cells Carrying four copies of pAL21 showing foreshortened snout, stumpy limbs, and a hunched back (arrows) caused by severe kyphosis. Degree of chimerism as determined by estimation of pAL21 copy number in seven different tissues from C21.6 with reference to an endogenous gene (type X collagen) varied from 18-59% (data not shown). Vandenberg et al., 1991; Spranger and Maroteaux, 1990; Horton and Hecht, 1993) where the mutant phenotype can be attributed to the presence of aberrant type II collagen molecules in the matrix. But the pAL21 phenotype is not caused by a mutation in the Col2a-1 gene. Several lines of evidence show that the skeletal abnormalities seen in the COL2A1-Tag transgenic mice could be specifically attributed to the transgene. First, the common skeletal abnormality found in large numbers of different pAL21 mice excludes the possibility of an integration site-specific effect. Second, pAA2 transgenic mice showed a lower frequency of unrelated abnormality suggesting that the skeletal abnormalities in ~AL21 mice were not due to a competition for Co12a-1 transcription factors caused by the integration of the COL2A1 sequences.
Third, the detection of Tag in some 12.5-d embryos in advance of chondrogenesis, the ability of the COL2A1 sequences in pAL21 and pAA2 to direct expression of the transgenes to the major sites of expression of Col2a-1, and the correlation between the type of affected tissues in pAL21 transgenic fetuses and the known sites of expression of the Col2a-1 gene during embryogenesis (Table 1II and [Cheah et al., 1991] ) implicate Tag as the cause of the skeletal malformations. Levels of expression of Tag varied in different transgenics since each of these differ in copy number and integration site. Tag may also be inappropriately expressed in some cases because of the influence of genomic sequences at the site of transgene integration. This is normal for transgenic experiments. It is likely that the presence of Tag precedes the appearance of abnormality and although Tag could not be demonstrated in all abnormal pAL21 mice when they were assayed, previous Tag expression cannot be excluded. Tag found in some mice with no clear abnormality could represent a combination of inappropriate timing, low level of expression of the transgene and/or mosaic expression since Tag levels were very low and immunostaining was patchy.
Several observations suggest that the chondrodysplastic phenotype in pAL21 transgenic mice may be caused by an impaired or retarded ability of chondrocytes to differentiate fully. First, there was a correlation between reduction in chondrocyte densities and abnormalities in cartilaginous tissues of some pAL21 fetuses (Figs. 5 and 7) . Second, in five abnormal pAL21 18.5-d fetuses showing disproportionate limb reduction, there was reduced chondrocyte density in the growth plate of the humerus (Table IV) . Third, in some abnormal pAL21 transgenic neonates there was reduced hypertrophy of chondroeytes and a paucity of matrix (Figs. 4 and  7) . Endochondral ossification was also less advanced compared to nontransgenic littermates (Fig. 5) . These phenotypic deviations are consistent with an immature state of differentiation (Horton, 1993) . Fourth, islands of cells which expressed Tag and were improperly organized were found in the articular and growth plate cartilage of 15.5-d chimeric fetuses and in chondrodysplastic pAL21 chimeric neonates. Because Tag expression could be detected in some transgenic embryos as early as at 12.5 d and reduced chondrocyte densities were found at 15.5 d, an effect of Tag on proliferation cannot be excluded. However such an effect would have to be tested for using specific assays such as thymidine uptake studies.
In the chimeras, the expression of cartilage characteristic genes (type IIB, long form od(IX), a2(XI) collagens and aggrecan) and the absence of type I collagen mRNA by the disorganized cells within the islands, indicate that they were chondrocytes. The presence of disorganized chondrocytes at fetal as well as neonatal stages and the absence of expression of type X, type HA, and short form type IX collagens by these cells (Fig. 8) , suggest that in the chimeras, pAL21-derived ceils can undergo chondrogenesis but there is retardation or failure of progression to the final stages of proliferation, terminal differentiation, and hypertrophy. The absence of type X collagen expression in the islands of cells in the chimeras also suggest that the chondrodysplastic phenotype in Tag mice is not simply a consequence of lowered levels of type II collagen expression. Because the ESderived chondrocytes fail to participate properly with the host cells in columnar organization, this disrupts the growth plate. The reduction in proliferating and hypertrophic chondrocytes found for pAL21 transgenic mice correlates well with these findings and suggests that retarded differentiation is the more likely. In transgenics there was no disorganization probably because all the cells were behaving similarly. Instead poorer or retarded differentiation and/or proliferation would result in fewer numbers of chondrocytes and a reduction of cartilage size. This defect in differentiation was probably not restricted to the growth plate since other cartilages, such as nasal septum, base of skull, vertebrae, and otic capsule were malformed in some transgenics and chimeras.
It is worth noting that disorganized and densely packed immature chondrocytes have been observed in some examples of human chondrodysplasias where the molecular basis of the disease is unknown (Horton and Hecht, 1993 ). An example is thanatophoric dysplasia, which is characterized by a lack of organized chondrocytes and a reduction in numbers of proliferative and hypertrophic chondrocytes suggesting a defect in differentiation/proliferation. Reduced chondrocyte proliferation has recently been reported in a short rib syndrome type Beemer patient (Brenner et al., 1993) . In addition lethal skeletal dysplasia in mice lacking parathyroid hormone-related peptide has been shown to be associated with premature maturation of chondrocytes (Karaplis et al., 1994) . Cultured SV40 transformed chondrocytes dedifferentiate and downregulate type II collagen gene expression (Thenet et al., 1992) , although an exception has been reported recently (Mallein-Gerin and Olsen, 1993) . Those cultured SV40 transformed mouse chondrocytes which maintained phenotype were, however, unable to undergo hypertrophy (Mallein-Gerin and Olsen, 1993) . It is of note that there was a reduction in the number of hypertrophic chondrocytes in some of the pAL21 transgenic mice and an absence of type X collagen expression in pAL21-ES cell-derived disorganized chondrocytes in the chimeras. Levels of expression of cd0I) collagen mRNAs were reduced in abnormal transgenies and for those disorganized groups of chondrocytes seen in the chimeras. Restriction of these changes to the islands of cells suggest the effect of Tag is cell autonomous. One way Tag is thought to cause changes in transcriptional activity is by mediating the modification or induction of cellular DNA-binding factors (Stahl and Knippers, 1987; Gallo et al., 1990 ). An examination of the 5' flanking region and first intron of the human and mouse od(II) collagen genes (Vikkula et al., 1992) reveals the presence of several se-quence motifs known to bind Tag (DeLucia et al., 1983) . Tag has also been shown to alter the cell-cycle duration of exponentiallly growing cells (Sladek and Jacobberger, 1992) . Therefore, Tag could have interfered with the expression of the Col2a4 gene and the terminal differentiation of chondrocytes in the pAL21 transgenic mice.
To determine the precise cause of the chondrodysplasia in pAL21 mice, it would be important to distinguish if abnormal chondrocyte differentiation was the primary consequence of Tag expression or was secondary, as a response to Tag-induced downregulation of type H collagen expression. A developmental study of Tag expression and the onset of abnormal chondrocyte differentiation in the chimeras as well as identification of the gene targets for Tag action, will help address this question. Since levels of type II collagen expression were reduced not ablated, an additional approach could be to determine the consequence of introducing pAL21 into the germline of phenotypically normal transgenic mice which overexpress type H collagen such as those described by Garofalo et al. (1993) . One could also determine if there were abnormalities in chondrocyte differentiation where Col2ad is downregulated, such as may be found for mice heterozygous for a null mutation in the gene created by gene targeting.
The lack of hyperplasia or tumor formation in pAL21 mice is intriguing. In the majority of Tag transgenesis studies, the gene has been controlled by viral promoters, or regulatory elements of genes which are expressed either widely or in specific tissues with expression extending into adulthood. Targeted expression of Tag or integration of the early region of SV40 virus in mice usually promotes tumorigenesis in specific tissues after birth (Hanahan, 1988; Adams and Cory, 1991) . The phenotypic consequence of tissue specific and restricted expression of Tag during embryogenesis is poorly understood. We have found previously that expression of the al0I) collagen gene declines after birth with little expression once growth ceases . Perhaps this additional imposition of a developmentally regulated schedule which restricts Tag expression to embryonic and growth phases of development is the reason for the absence of tumors in pAL21 mice. Tumor promotion may require sustained postnatal expression of Tag to enable synergistic factors to act. Whether some cell types may be refractory to Tag action with respect to tumor promotion is controversial. In a recent report, SV40 transformed murine chondrocytes which retain their differentiated phenotype failed to produce tumors in mice, suggesting that in chondrocytes, Tag expression alone is not sufficient for tumor promotion (Mallein-Gerin and Olsen, 1993) . Targeted expression of Tag via the opsin gene promoter to the retina of transgenic mice results in selective proliferation followed by the degeneration of rod photoreceptor cells (AI-Ubaidi et al., 1992) . Transgenic mice expressing Tag under the control of the myelin basic protein promoter displayed hypomyelination and neurological disturbances such as convulsions and hindlimb ataxia (Jensen et al., 1993) . These findings indicate that hyperplasia or a predisposition to tumor formation, although common, is not the only consequence of expression of Tag in transgenic mice.
Despite the apparent similarity of the phenotype displayed by pAL21 transgenic mice and other mice expressing mutant Col2a-1 alleles (Mets~anta et al., 1992; Garofalo et al., 1991; Vandenberg et al., 1991) , the chondrodysplasia of pAL21 mice has not been caused by a structural alteration of a matrix molecule but may be due to a poorer differentiation of chondrocytes. The recent reports of abnormalities in chondrocyte proliferation and maturation in examples of skeletal dysplasia in human and mouse (Brenner et al., 1993; Karaplis et al., 1994) support the possibility that multiple causative factors apart from impaired integrity of matrix components may also result in chondrodysplasia. The COL-2A1-Tag transgene provides a tool for investigating this possibility and for analyzing the complex relationships between quality of cartilage matrix, chondrocyte differentiation, and phenotype during skeletogenesis and the pathogenesis of chondrodysplasia. The use of ES cells and chimeras also provides a useful approach for overcoming the problem of perinatal lethality when transgenes produce dominant mutations in matrix genes.
